E. Kirk Neely
Publication Details
-
Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: a multicenter trial.
J Clin Endocrinol Metab. 2007; (5): 1697-704
GnRH analog (GnRHa) therapy for central precocious puberty (CPP) typically involves im injections. The histrelin implant is a new treatment that provides a continuous slow release of the GnRHa histrelin.
Help